93
Gene, 48 (1986) 93-100 Elsevier GEN 01794
Differential utilization of Staphylococcus aureus promoter sequences by Escherichia coli and Bacillus subtilis (Recombinant DNA; shuttle vectors; chloramphenicol acetyltransferase; analysis)
gene expression; plasmids; dot-blot
Michael C. Hudson and George C. Stewart * Department of Microbiology, University of Kansas, Lawrence, KS 66045 (U.S.A.) Tel. (913)864-4229 (Received
July 16th, 1986)
(Revision
received
(Accepted
September
September
1 lth, 1986)
12th, 1986)
SUMMARY
Promoter-cloning plasmids were constructed and have been used to isolate transcriptionally active DNA fragments from Staphylococcus aureus. The plasmids contain a chloramphenicol acetyltransferase (CAT) gene of Gram-positive (G + ) origin which lacks both its promoter and the sequence responsible for CAT inducibility. The ability of S. aureus promoters to direct CAT expression in Escherichia coli and Bacillus subtilis was examined. Two classes of staphylococcal promoter sequences have been obtained. Class I DNA fragments direct CAT expression in S. aureus, B. subtilis, and E. coli, while class II DNA sequences direct CAT expression only in the G + hosts.
INTRODUCTION
Mechanisms for the regulation of gene expression in G + organisms have not been characterized as well as those of their G - counterparts. Certain G + bacteria, namely B. subtilis and Streptomyces coelicolor, can effect changes in gene expression by a modification of RNA polymerase through replacement of
* To whom
correspondence
and
reprint
requests
should
be
addressed. Abbreviations:
bp, base
Cm, chloramphenicol;
pair(s);
G -
tive; kb, 1000 bp; Km, kanamycin; sensitivity, tryptic
sensitive;
0
Cm acetyltransferase; G + , Gram-posi-
R, resistance,
Sm, streptomycin;
soy agar; TSB, tryptic
0378-l 119/86/$03.50
CAT,
, Gram-negative;
resistant;
Tc, tetracycline;
‘,
TSA,
soy broth.
1986 Elsevier
Science Publishers
B.V. (Biomedical
the normal (r subunit of the enzyme (Losick and Pero, 198 1; Gilman and Chamberlin, 1983; Westpheling et al., 1985). Studies with other bacterial species have not progressed sufficiently to determine whether a a factor switching mode of gene regulation is common to G + bacteria or is a property unique to the spore formers. The promoter sequences recognized by the minor forms of B. subtilis RNA polymerase differ from the consensus promoter sequence recognized by the major holoenzyme found in vegetatively growing cells (E-o”~) (Moran et al., 1982; Johnson et al., 1983). If minor forms of RNA polymerase play a role in gene expression in other G + bacteria, one might expect to find transcriptional regulatory signals in these organisms which would not be recognized by the B. subtilis E-o~~. These sequences would also Division)
94
likely not be recognized polymerase holoenzyme this enzyme
recognizes
moter sequence
by the predominant RNA found in E. coli (E-a7’), as the same
consensus
pro-
as B. subtilis E-d3.
The G + bacterium
and Quigley (1981). S. uureus chromosomal
was isolated as described (Dyer and Iandolo, 1983). Preparation of competent E. coli cells and transformation
S. cLureu.sis the etiologic agent
was as previously
Ehrlich,
1979). Competent
of a number of diseases in man and animals including
pared as described
mastitis,
S. aureus
nosocomial
infections,
drome, and toxic shock syndrome Although
the cloned
scalded
(Gemmell,
S. uureus cc-hemolysin
et al., 1983), lipase (Lee and Iandolo, toxin
A (Betley
skin syn-
et al., 1984), and
1982). (Kehoe
1985), enterostaphylococcal
protein A (Duggleby and Jones, 1983; Lofdahl et al., 1983) genes are expressed from their own promoters in E. coli, the S. aureus enterotoxin B and exfoliative toxin B genes were found not to be expressed in this host (Ranelli et al., 1985; Jackson and Iandolo, 1986). The lack of expression in the G - organism was believed to be due to poor sequence conservation between the staphylococcal gene promoters and the consensus E. coli/B. subtilis promoter sequence. This paper describes the isolation and preliminary characterization of S. aureus DNA sequences which display promoter activity. Expression directed by staphylococcal sequences has been compared in B. subtilis, S. aureus, and E. coli hosts and a subset of these DNA fragments was found not to promote transcription when introduced into E. coli.
EXPERIMENTAL
AND DISCUSSION
(a) Bacterial strains The bacterial strains used in this study were E. coli strain HB 101 (Boyer and Roulland-Dussoix, 1969), B. subtilis strain AH1 (strain 168 ZeuA8 which carries a chromosomal insert of Tn917; A. Honeyman, personal communication), and the S. aureus 8325-4 derivative strains RN4220 (Kreiswirth et al., 1983) and KUS74 (Breidt and Stewart, 1986). The former is a restrictionless mutant while the latter is a Tn551 mutant which constitutively expresses phospho-jIgalactosidase. (b) DNA isolation
and transformation
Plasmids were isolated (Norgard, 1981) from E. coli and minilysates were prepared as by Holmes
DNA
formed
(Erickson
protoplast
as described
that regeneration
reported
(Dagert
and
B. subtilis cells were preand Copeland,
transformations (Murphy
were
1972). per-
et al., 1981) except
agar was used (Stahl and Pattee,
1983). Selective concentrations of antibiotics were: Cm, 5 pg/ml; Km, 4 pg/ml for B. subtilis and 20 pg/ml for S. aureus;
Sm, 100 pg/ml;
and Tc, 15 pg/ml.
(c) CAT assays Cell lysates were prepared grown in antibiotic-containing
as follows. Cells were TSB to a density
giving an absorbance (AeoO for E. coli, A 540 for S. uureus, A so0 for B. subtilis) of 0.4. Cells from 2 ml of culture were harvested by centrifugation (3090 x g) and resuspended in 175 ~1 WL buffer (25 mM Tris. HCl, 10 mM EDTA, pH 8.0; Norgard, 1981). This cell suspension was transferred to 1.5 ml microfuge tubes. B. subtilis and E. coli cells were treated with 250 pg lysozyme while S. aureus cells were treated with 50 pg lysostaphin (Sigma Chemical Co.). All cultures were incubated for 30 min at 37°C. The cell lysates were then centrifuged (13000 x g) for 10 min and the resulting supernatant was held on ice. CAT assays were performed on the samples by the spectrophotometric method (Shaw, 1979). CAT specific activity is expressed as nmol Cm acetylated/min/mg dry weight of cells. (d) Determination
of plasmid copy number
The procedure used was as described (ScheerAbramowitz et al., 1981) except that unlabeled, purilied plasmid DNA (0.3 pg) was added to each [ 3H]thymidine (ICN Pharmaceuticals, Inc.)-labeled sample to facilitate visualization of the open circular as well as the closed circular plasmid forms. Copy numbers (plasmid molecules per chromosome equivalent) were calculated based upon experimentally determined plasmid sizes and utilizing a value of 4.0 x lo6 bp for the size of the chromosomes of S. aureus, B. subtilis, and E. coli.
95
(e) Dot blot analysis of RNA
moter and sequences repsonsible for induction of the antibiotic resistance. We have modified this plasmid by (1) incorporation of the TcR determinant from pBR322 to provide a better selective marker for cloning into E. cob; (2) positioning the XbaI to EcoRI linker from pUC13 (Messing, 1983) in front of the CAT gene to increase the number of useful cloning sites, and (3) positioning a transcriptional terminator upstream from the cloning sites to reduce background transcription from endogenous plasmid promoters (Band et al., 1983; Brosius, 1984). Two derivative plasmids were constructed (Fig. 1). Plasmid pMH109 retained the replication
was performed as Dot blot hybridization described (Truitt et al., 1985). Nick-translated pC194 (Horinouchi and Weisblum, 1982) was used as the hybridization probe for the CAT-specific sequences. Hybridization conditions used were as described (Berent et al., 1985). (f) Plasmid constructions
The promoter-cloning plasmid pCPP-3 (Band et al., 1983) utilized a CAT gene deleted of its pro-
X BSmSsE
1
X BSmSsE
Tc
Tc
I\
Fig. 1. Maps ofpMH109 1981), which includes entire pSA0501 functions.
and pMHl20.
plasmid
(Gryczan
The CAT gene, 1,
transcription
also carry the TcR determinant
fragment
ofE. coli DNA polymerase
polylinker PvuII;
from pUC13 terminator
Sm, SmuI;
(Messing, preceding
pMH109
1978). pSA0501
terminator, from pBR322
and pBR322
origin of replication
are from pCPP-3
as an EcoRI-AvuI
pMH120
and temperature-sensitive fragment,
(Jalanko
et al.,
contains
the
replication
(Band
et al., 1983). Both
blunt-ended
using the Klenow
site of pCPP-3 which was similarly filled-in. The XbaI to EcoRI The plasmid
sites are as follows: B, BumHI;
areas originated
from pUBll0
in G + hosts. The plasmid
the SmR determinant
in the two vectors.
sites. Restriction site.
functional
which was isolated
1983) was also included the cloning
rbs, ribosome-binding
the 4.0-kb XbaI to PvuII fragment
provides
I, and ligated into the single EarnHI
Ss, SstI; and X, XbuI. The stippled
the CAT determinant.
contains
and an origin of replication
and Dubnau,
plasmids
transcription
The plasmid
the KmR determinant
from either pUBI
pMHl20 Bg, &/II;
or pSA0501
additionally E, EcoRI;
contains
t,
H, HindHI;
while the blackened
a P,
area is
96
functions of pUBll0 (Jalanko et al., 1981) but contained more of PUB 110 than the PvuII-EcoRI fragment found in pCPP-3 (Band et al., 1983). The inclusion of the additional EcoRI-XbuI fragment provided transcription termination functions and thus reduced background expression of CAT (compare pMH104 which lacked this fragment to pMH109 in Table I). The plasmid pMH120 was constructed by replacing the PUB 110 region with the staphylococcal plasmid pSA0501 (Gryczan and Dubnau, 1978; Gryczan et al., 1980). This plasmid confers Sm resistance and is a temperature-sensitive replicon. Thus this plasmid is useful for procedures where curing of the plasmid or chromosomal integration of
TABLE
plasmids carrying homologous inserts is desirable. The 28-bp trp a transcription terminator (Pharmacia, Inc.) was positioned upstream from the CAT gene, which reduced background CAT expression eightfold in E. coli hosts (compare pMH120 with pMHll0 [minus this terminator] in Table I). (g) Isolation and characterization moter-containing
of S. uureus pro-
fragments
The data in Table I were obtained from representative experiments ultilizing pMH 109. The plasmid was digested with SmaI, treated with bacterial alkaline phosphatase, and ligated to &I-cleaved S. uureus chromosomal DNA. AlaI cleaves the
I
Quantitative
analysis
of plasmid
functions
Host
Plasmid
Resistance
organism
Size
CAT
(bp)
specific
COPY number b
Stability” (%)
activity” pSA0501
s. al0Wu.s
Sm
4200
-
40
pUBll0
B. subtilis
Km
4500
-
63
pMH104
E. coli
Tc
7000
0.5
NDd 33
pMH109
E. coli
Tc
7400
0”
pMHl09
B. subtilis
Km
7400
0.3
6
6
pMH109
S. aureus
Km
7400
0
10
88
pMH109-16
E. coli
Tc, Cm
8500
24.5
29
pMH109-16
B. subtilis
Km, Cm
8500
34.4
4
pMH109-16
S. aureus
Km, Cm
8500
8.6
4
pMH109-18
E. coli
Tc, Cm
8700
2.3
49
pMH109-18
B. subtilis
Km, Cm
8700
77.5
6
pMH109-18
S. aureus
Km, Cm
8700
6.1
10
pMH109-20
E. coli
Tc, Cm
8300
3.9
62
pMH 109-20
B. subtilis
Km, Cm
8300
16.0
5
pMH109-20
S. aureus
Km, Cm
8300
4.4
5
pMH1 IO
E. coli
Tc
7700
1.3
ND
pMH120
E. coli
Tc
7800
0.2
28
pMH120
S. aureus
Sm
7800
a Expressed
as nmol Cm acetylated/min/mg
b Expressed
as number
’ Plasmid-carrying aeration
of plasmid
Km-containing
cells (dry weight). Values represent
molecules
strains were grown overnight
at 37°C to a density
of approx.
TSA. % of KmR colonies
per genome
equivalent.
in TSB without
lo9 colony
forming
units/ml.
is given.
= 0.06 nmol/min/mg
cells (dry weight).
averages
1 of two or more determinations.
The values are averages
antibiotic
d Not determined. e Lower limit of detection
ND
selection. Aliquots
0.2 37
of three or more determinations.
were diluted
The cells were then diluted
1: 10 in TSB and grown with
in TSB and plated
on TSA and
S. uureus genome more extensively than does SmaI. Ligated plasmids were introduced into E. coli strain HBlOl by transformation. Clones with plasmid inserts demonstrating promoter activity were obtained by direct selection of transformants on Cmcontaining media. Plasmids containing putative S. uureus promoters were introduced into B. subtilis by competent cell transformation and into S. uureus by protoplast transformation. The level of CAT expression for three representative plasmids, pMH109-16, pMH 109-18, and pMH109-20 is given in Table I. Each plasmid contains an insert approx. l-2 kb in size and CAT assay values were used as an indication of cloned promoter strength. However, at this stage, differences related to translation or enzyme stability could not be distinguished from differences in transcriptional activity. Data shown in Table I demonstrate the absence of measurable CAT expression in clones carrying pMH109. Only B. subtilis exhibits very slight activity. CAT activities for clones carrying pMH 109 or pMH 120 are well below that of their precursors (pMH 104 and pMH 110, respectively) which lack the transcription terminator sequences ustream from CAT. Although pMH109-16, pMH109-18, and pMH109-20 contain cloned S. aureus promoter sequences, CAT activity is highest in B. subtilis for all three plasmids (which is true for all clones which we have thus far characterized). This phenomenon is particularly apparent for pMH109-18 for which there is 13 times the CAT activity in B. subtdis relative to the value obtained with S. uureus. This difference becomes even greater when plasmid copy numbers are considered. The lower enzyme activities obtained with S. uureus are not an artifact resulting from the usage of lysostaphin during cell lysis. The addition of lysostaphin (in addition to lysozyme) to B. subtilis cultures has no effect on resulting CAT yields (not shown). To ascertain whether differences in CAT activities were due to gene dosage, plasmid copy numbers were determined and are also presented in Table I. The plasmids pSA0501 and PUB 110 are maintained at a high copy number in their G + host cells. However, as can be seen in Table I, the copy numbers of these staphylococcal plasmids decrease dramatically with increased plasmid size. For example, with the PUB 1lo-derivatives, the addition of 4.0-4.3 kb of DNA to this plasmid results in a
IO-16-fold reduction in plasmid numbers in the cells. During the construction of pMH120, the addition of 3.6 kb of DNA to the pSA0501 plasmid decreased its copy number 40-fold in S. uureus. Less dramatic reductions in copy numbers have been observed during the construction of B. subtilis chimeric plasmids (Scheer-Abramowitz et al., 1981). However, it has been reported that an increase in the size of PUB 1lo-derived recombinant plasmids strongly reduced their copy numbers and segregational stability in B. subtilis hosts (Bron and Luxen, 1985). The segregational stability of plasmids pMH109 and pMH109-18 in B. subtjlis and S. uureus was determined (Table I). The plasmids are more stably maintained in S. uureus than in B. subtilis. This increased retention was not due to integration of the plasmid into the staphylococcal chromosome at the site of homology to the insert. We have found that Campbell-type integration of plasmids into homologous sites in the staphylococcal chromosome is a very low frequency event (B. Oskouian and G.C.S., unpublished observations). The plasmids are certainly structurally stable and can be maintained in cultures with antibiotic selection. (h) Isolation of S. sureus promoters which do not function in E. coli
Plasmid constructions were as described (section g) except that plasmid transformants of HBlOl were selected on Tc-containing media. TcR clones were toothpick-inoculated onto Cm-containing media. All TcR, CmS E. coli clones were pooled and plasmid DNA was isolated. This plasmid DNA mixture was then introduced into S. uureus protoplasts with Cm selection. The resulting colonies presumably represented clones carrying recombinant plasmids with staphylococcal promoters not recognized by E. coli. These plasmids, when reintroduced into E. coli, did not direct CAT expression, indicating that rearrangements of the plasmid DNA were not responsible for the CAT expression in the S. uureus host. Six representative plasmids which directed CAT expression in S. uureus but not E. coli hosts were introduced by transformation into B. subtilis. The insert fragment size and CAT-specific activities indicated that each of these inserts represented a unique
98
TABLE
II
CAT-specific Plasmid
activities
directed Insert
by ‘staphylococcal size (bp)
inserts
in the three hosts
CAT specific activity a B. sub&
S. aureus
E. coli Ob
pMH109-01
530
36.5
1.1
pMHl09-03
730
8.4
0.5
0
pMH109-012
750
52.3
0.8
0
pMH109-013
73
13.1
0.9
0.2
pMH109-014
610
18.8
1.2
0
pMH109-015
131
30.6
2.9
0
a nmol/min/mg
cells dry weight.
’ Lower limit of assay = 0.06.
fragment from the staphylococcal chromosome. Table II summarizes the results obtained when CAT assays were done with the three host species carrying these plasmids. With the exception of pMH109-013, E. coli clones carrying the recombinant plasmids do not demonstrate detectable CAT activity. However, the plasmid inserts did promote CAT expression in the B. subtilis host. As was the case with the promoters in Table I, B. subtilis demonstrated higher levels of CAT activity than S. aureus, even though the cloned sequences were of staphylococcal origin.
plasmids pMH109-16 and pMH109-013. These two plasmids gave high and low levels of CAT-specific activity, respectively (Tables I and II). However, the amount of cat mRNA consistently did not correlate with the level of CAT-specific activity obtained. The hybridizing species from these two strains was not contaminating plasmid DNA as the hybridizing signal was destroyed when the RNA preparation was treated with RNase (previously boiled to inactivate DNase). The hybridizing species was also not affected by treatment with DNase (data not shown).
(i) RNA dot-blot analysis The failure to detect CAT expression in E. coli could have been a result of a failure to recognize the staphylococcal promoter sequences (a transcriptional failure) or may have been due to a translational block (despite the CAT gene on pMH109 being immediately preceded by a ribosome binding site recognizable in E. co/i). To resolve these possibilities, RNA dot blot analysis was carried out on the E. coli clones carrying the recombinant plasmids. Decreasing amounts of total cellular RNA was spotted onto a nitrocellulose filter, which was then 32P-labeled pC194. The only RNA probed with species with homology to this plasmid probe would be CAT mRNA. CAT gene-specific mRNA was not detected in E. coli clones lacking CAT activity with the exception of low levels seen with pMH109-015bearing cells (Fig. 2). Such sequences were detected in the RNA from E. coli clones harboring the
012 013 014 015 Fig. 2. Dot clones
blot analysis
carrying
amount
of CAT
G + -specific
CAT
of total RNA applied
eliminate
pretreated
DNase
from E. coli
isolated
expression
plasmids.
to the filter ranged
62.5 ng. The last three columns RNA samples
RNA
on the right ofthe figure represent
with RNase (50 pg/ml, heat-treated
activity). The plasmids
carried
on the let? (with the ‘pMH109-’
the designations).
Samples
16Ec and
(see Tables I and II).
to
by the different
clones are indicated controls
The
from 1 pg to
013 serve
deleted from as positive
99
(j) Conclusions
ACKNOWLEDGEMENTS
The results presented demonstrate that S. aureus DNA fragments can be isolated which direct the expression of a promoterless gene. Two classes of promoter-containing DNA fragments were observed. Class I promoters function in S. aureus, B. subtilis, and E. coli and presumably represent promoters whose sequence resembles the consensus E. coli E-07’/B. subtilis E-d3 promoter sequence. Based upon its expression pattern, the cloned ahemolysin gene carries a class I type promoter (Fairweather et al., 1983; Kehoe et al., 1983). Class II promoters are recognized by S. aureus and B. subtilis but not by E. coli. These fragments may (1) carry promoters which require a positive regulatory factor common to the G + bacteria but not found in E. coli; (2) signify a promoter sequence tolerated by the polymerase in the G + organisms but not by the E. coli holoenzyme; or (3) represent promoters recognized by a minor form of 0 factor possessed by both S. aureus and B. subtilis. Each staphylococcal promoter-containing insert that has been characterized is able to direct CAT expression in B. subtilis. In fact, CAT-specific activities are always highest for B. subtilis even though the sequence cloned upstream from CAT is from the S. aureus genome. Determinations of CAT-specific activities were performed on early log-phase B. subtiliscells carrying the recombinant plasmids. The RNA polymerase holoenzymes E-d3 and E-02’ are present in B. subtilis cells at this stage of growth, but promoters recognized by these two forms of Bacillus RNA polymerase are also recognized by E. coli (Moran et al., 1982; Gilman and Chamberlin, 1983). Currently, it is unknown which form(s) of B. subtilis RNA polymerase recognizes the cloned S. aureus sequences. Our results are somewhat surprising in that B. subtilis has been believed to be more stringent than E. coli in the recognition of transcriptional and translational signals from other organisms (Kreft et al., 1978; Moran et al., 1982). The data presented in this paper indicate that significant differences seem to exist between gene expression in S. aureus and E. coli. Studies are currently in progress to determine the nucleotide sequence of these cloned S. aureus promoters as well as the directed start points of transcription.
We thank Dennis Henner for providing us with the plasmid pCPP-3. This work was supported by Public Health Service grant AI21574 from the National Institutes of Health and by University of Kansas General Research allocation 3637-X00038.
REFERENCES Band,
L., Yansura,
vector
D.G. and Henner,
for cloning
D.J.: Construction
of a
in Bacillus subtilis. Gene
promoters
26
(1983) 313-315. Berent, S.L., Mahmoudi,
M., Torczynski,
Bollon, A.P.: Comparison fragments
as probes
R.M., Bragg, P.W. and
of oligonucleotide
in DNA
and
Northern,
colony and plaque hybridizations.
May/June
(1985) 208-220.
Betley, M.J., Lofdahl, Novick,
S., Kreiswirth,
R.P.: Staphylococcal
ciated with a variable
and long DNA
RNA
dot,
Southern,
BioTechniques
B.N., Bergdoll,
enterotoxin
M.S. and
A gene is asso-
genetic determinant.
Proc. Natl. Acad.
Sci. USA 81 (1984) 5179-5183. Boyer,
H.W.
analysis
and
Roulland-Dussoix,
of the restriction
D.: A complementation
and modification
of DNA in Es&e-
richiu coli. J. Mol. Biol. 41 (1969) 459-472. Breidt Jr., F. and Stewart,
G.C.: Cloning
Escherichia coli. J. Bacterial. Bron,
S. and Luxen,
and expression
166 (1986) 1061-1066.
E.: Segregational
derived recombinant
of the
gene of Staphylococcus aureus in
phospho-/l-galactosidase
instability
of pUBllO-
in Bacillus subtilis. Plasmid
plasmids
14
(1985) 235-244. Brosius, J.: Plasmid vectors for the selection
of promoters.
Gene
27 (1984) 151-160. Dagert,
M. and Ehrlich,
chloride
improves
S.D.: Prolonged
incubation
in calcium
of E. coli cells. Gene
the competence
6
(1979) 23-28. Duggleby,
C.J. and Jones,
S.A.: Cloning
and expression
of the
Staphylococcus aureus protein A gene in Escherichia coli. Nucl. Acids Res. 11 (1983) 3065-3076. Dyer,
D.W. and Iandolo,
J.J.: Rapid
isolation
Staphylococcus aureus. Appl. Environ.
of DNA
Microbial.
from
46 (1983)
283-285. Erickson,
R.J. and Copeland,
chromosomes teriol.
J.C.: Structure
and replication
of
cells of Bacillus subtilis. J. Bac-
in competent
109 (1972) 1075-1084.
Fairweather,
N., Kennedy,
S., Foster,
T.J., Kehoe,
Dougan,
G.: Expression
of a cloned
Staphylococcus aureus
a-hemolysin
determinant
cus aureus. Infect. Immun. Gemmell, Gilman,
in Bacillus subtilis and Staphylococ41 (1983) 1112-l 117.
C.G.: The staphylococcus
after its discovery.
polymerase.
- new features
100 years
J. Infect. 4 (1982) 5-15.
M.Z. and Chamberlin,
regulation
M. and
M.J.: Developmental
of Bacillus subtilis genes transcribed Cell 35 (1983) 285-293.
and genetic by a**-RNA
Gryczan,
T.J. and Dubnau,
chimeric
D.: Construction
and properties
of
in Bacillus subtilis. Proc. Natl. Acad.
plasmids
Sci.
USA 75 (1978) 1428-1432. Gryczan,
T.J., Shivakumar,
tion of chimeric J. Bacterial. Holmes,
cloning
D.: Characteriza-
D.S. and Quigley, of bacterial
M.: A rapid boiling method plasmids.
Anal. Biochem.
for the
114 (198 1)
S. and
functional
Weisblum, resistance.
M.P. and Iandolo,
that specifies
J. Bacterial.
and
inducible
150 (1982) 8 15-825.
J.J.: Cloning
and expression
of the
A., Palva,
plasmids Johnson,
I. and Soderlund,
pUBll0
W.C.,
polymerase between
Moran
Jr., C.P. and
overlapping
lated gene. Nature
promoters
aureus a-hemolysin
Losick,
R.: Two
RNA
for a developmentally
regu-
and mapping
N. and Dougan,
of the Staphylococcus
in Escherichiu cob’ K-12.
determinant
K. and Goebel,
Enzymol.
S.F.J., Lee, G., Stephens,
J. and
that signal the initiation
B.N.,
Schlievert,
P.M., Bergdoll,
syndrome
transmitted
Lofdahl, exotoxin
by a prophage.
Lee, C.Y. and Iandolo, of lipase
E., Phillips,
isolation
Losick,
oftranscription Gen.
M.,
R.: Nucleotide and trans-
Genet.
186 (1982)
S.,
Betley,
M.J.,
M.S. and Novick, structural Nature
S., Edelman,
and characterization
plasmids
Q’Reilly,
M.,
R.P.: The toxic
gene is not detectably
Norgard,
M.V.: Rapid
and simple
RNA from plasmid
of bacteriophage
con-
in Staphylococcus aureus. J. Bac-
DNA without
Gene for staphylococcal USA 80 (1983) 697-701.
protein
L. and Lindberg,
M.:
A. Proc. Natl. Acad.
Sci.
Plasmid
removal
of contaminating
the use of RNase.
Anal.
113 (1981) 34-42.
Proc. Natl. Acad. Scheer-Abramowitz, and mode
enterotoxin
G.J. and Khan,
B gene is chromosomal.
Sci. USA 82 (1985) 5850-5854. J., Gryczan,
of replication
T.J. and Dubnau,
of plasmids
pE194
D.: Origin
and pUBl10.
6 (1981) 67-77.
Shaw, W.V.: Chloramphenicol phenicol-resistant
acetyltransferase
bacteria.
Methods
from chloram-
Enzymol.
43 (1979)
737-755. mapping J. Bacterial. CL.,
P.A.: Computer-assisted
by protoplast
fusion
Wang, W.G.: Isolation expression
(E-2’).
J., Ranes,
heterogeneity
J.E., Da-Jian,
2. and Halden-
of Bacillus subtilfi mutants
of a gene transcribed
RNA polymerase
J. Bacterial.
in
161 (1985) 515-522. R.: RNA polymerase
in Streptomyces coelicolor. Nature
by R.E. Yasbin.
altered
in vitro by a minor form of
M. and Losick,
22-27. Communicated
chromosome
in Staphylococcus aureus.
154 (1983) 395-405.
Ray, G.L., Trempy,
164 (1985) 288-293. S., Cuss, B., Uhlen, M., Philipson,
R.P.: Tn554:
insertions.
Ranelli, D.M., Jones, CL., Johns, M.B., Mussey,
Westpheling,
305 (1983) 709-712.
I. and Novick, of plasmid
5 (1981) 292-305.
Truitt,
J.J.: Mechanism activity
Murphy,
Stahl, M.L. and Pattee,
W.; Recombinant
in B. subtilis and E. coli. Mol. Gen.
of replication
Kreiswirth,
version
Pero,
in BaciNus subtilis. Mol.
lation
Plasmid
T., Fairweather,
162 (1978) 59-67.
shock
A.L.,
S.A.: Staphylococcal
41 (1983) 1105-1111.
Kreft, J., Bernhard, capable
of
302 (1983) 800-804. J., Foster,
expression,
Infect. Immun.
maps
from Bacillus subtilis discriminate
sigma factors
G.: Cloning,
H.: Restriction
and pBD9. Gene 14 (1981) 325-328.
Kehoe, M., Duncan,
Genet.
sequences
Biochem.
166 (1986) 574-580.
Jalanko,
teriol.
sequence
toxin B gene from Staphylococcus aureus. J. Bac-
exfoliative
Lofdahl,
B.: Nucleotide
map of pC194, a plasmid
chloramphenicol
teriol.
Methods
339-346.
193-197. Horinouchi,
Jackson,
for cloning.
Moran Jr., C.P., Lang, N., LeGrice, Sonenshein,
141 (1980) 246-253.
preparation
J.: New Ml3 vectors
101 (1983) 20-78.
in Bacillus subtik.
vehicles
of sigma factors. Cell 25 (1981)
582-584. Messing,
A.G. and Dubnau,
plasmid
Losick, R. and Pero, J.: Cascades
313 (1985)